Reshape Biotech

Reshape Biotech is a Danish startup with a mission to accelerate the pace of R&D in the biotech industry through the development of next-generation lab automation robots. The company's slogan, "Accelerating the pace of R&D," encapsulates its dedication to revolutionizing the biotech sector. Reshape Biotech's focus lies in enabling biotech companies to address significant global challenges such as alternative protein development and sustainable agriculture by providing them with the essential scaling factors. This allows researchers to collaborate globally on experiments and increase their throughput >500x. The startup boasts a highly multi-disciplinary team encompassing experts from various fields, ranging from PhDs in biology to hardware and software engineers. This diversity facilitates holistic collaboration and provides exposure to a truly vertical team dynamic. Founded in 2018, Reshape Biotech has made substantial progress and secured a significant $20.00M Series A investment on 09 April 2024. With a focus on Automation, Biotechnology, Robotics, and Machine Learning, Reshape Biotech has positioned itself as a leader in reshaping the biotech industry. Its impressive roster of investors, including Y Combinator, ACME Capital, Astanor Ventures, R7 Partners, 21st.BIO, Per Falholt, and Nicholas Francis, further underscores the company's potential for future growth and impact. Reshape Biotech's innovative approach and strong backing from industry leaders and top-tier investors make it a compelling player in the biotech sector, with the potential to redefine biotech research for the next 100 years.